Matters of the heart: late-breaking news from the American College of Cardiology Presented ByDr Rachel Giles, Medicom TrialRELIEVE-HF; EMPACT-MI ConferenceACC 2024 23 April, 2024 14:11
KARDIA-2: Add-on zilebesiran effectively lowers blood pressure Presented ByDr Akshay Desai, Brigham and Women's Hospital, MA, USA TrialPhase 2, KARDIA-2 ConferenceACC 2024 10 April, 2024 12:31
STEP-HFpEF DM: Semaglutide beneficial in patients with HFpEF and diabetes Presented ByProf. Mikhail Kosiborod, Saint Luke's Mid America Heart Institute, USA TrialPhase 3, STEP-HFpEF DM ConferenceACC 2024 9 April, 2024 11:53
IVUS-guided PCI beats angiography in patients with acute coronary syndrome Presented ByProf. Shao-Liang Chen, Nanjing Medical University, China TrialIVUS-ACS ConferenceACC 2024 11 April, 2024 16:19
To stent or not to stent? Favourable results for preventive PCI in vulnerable atherosclerotic plaques Presented ByProf. Seung-Jung Park, University of Ulsan College of Medicine; South Korea TrialPREVENT ConferenceACC 2024 11 April, 2024 16:17
Peripheral artery disease: procedure-guidance by IVUS superior to angiography Presented ByProf. Young-Guk Ko, Yonsei University, South Korea TrialIVUS-DCB ConferenceACC 2024 11 April, 2024 16:16
SGLT2 inhibition in heart failure more advantageous for women than men Presented ByDr Mounica Vorla, University of Louisville School of Medicine, KY, USA ConferenceACC 2024 11 April, 2024 16:14
Microaxial flow pump safes lives but comes with a price tag Presented ByProf. Jacob Møller, Odense University Hospital, Denmark TrialDanGer Shock ConferenceACC 2024 11 April, 2024 16:09
KARDIA-2: Add-on zilebesiran effectively lowers blood pressure Presented ByDr Akshay Desai, Brigham and Women's Hospital, MA, USA TrialPhase 2, KARDIA-2 ConferenceACC 2024 10 April, 2024 12:31
Safety of TAVI non-inferior to SAVR in patients with lower surgical risk Presented ByProf. Moritz Seiffert, BG University Hospital Bergmannsheil, Germany TrialDEDICATE-DZHK6 ConferenceACC 2024 10 April, 2024 12:28
New PCSK9 inhibitor achieves LDL-C goals in high-risk and very high-risk patients Presented ByProf. Eric Klug, University of the Witwatersrand, South Africa TrialPhase 3, LIBerate-HR ConferenceACC 2024 10 April, 2024 12:21
Protein drinks and exercise intervention improve physical performance in frail patients undergoing TAVR Presented ByDr Jonathan Afilalo, McGill University, Canada TrialPERFORM-TAVR ConferenceACC 2024 10 April, 2024 12:13
AEGIS-II: Negative primary endpoint but infusions might benefit subgroups of patients Presented ByProf. Michael Gibson, Harvard Medical School, MA, USA TrialPhase 3, AEGIS-II ConferenceACC 20 10 April, 2024 12:11
STEP-HFpEF DM: Semaglutide beneficial in patients with HFpEF and diabetes Presented ByProf. Mikhail Kosiborod, Saint Luke's Mid America Heart Institute, USA TrialPhase 3, STEP-HFpEF DM ConferenceACC 2024 9 April, 2024 11:53
RELIEVE-HF: Inter-atrial shunt might be advantageous in HFrEF Presented ByProf. Gregg Stone, Icahn School of Medicine at Mount Sinai, USA TrialRELIEVE-HF ConferenceACC 2024 9 April, 2024 11:52
BE ACTIVE shows that small incentives increase daily steps in high-risk patients Presented ByDr Alexander Fanaroff, Penn Medicine, Philadelphia, PA, USA TrialBE ACTIVE ConferenceACC 2024 9 April, 2024 11:49
“Inclisiran first” strategy highly effective regarding LDL control in ASCVD Presented ByDr Michael Koren, Jacksonville Center for Clinical Research, USA TrialPhase 3, VICTORION-INITIATE ConferenceACC 2024 9 April, 2024 11:46
Olezarsen highly effective in lowering triglycerides Presented ByDr Brian Bergmark, Brigham and Women's Hospital, USA TrialPhase 3, BRIDGE-TIMI 73a ConferenceACC 2024 9 April, 2024 11:42